Epilepsy & Seizures
News
Patients With Epilepsy and Obstructive Sleep Apnea Have More Frequent Seizures
Tuesday, September 25, 2018—A pilot study of 49 adult patients with refractory focal, generalized, or unclassified epilepsy syndromes enrolled prospectively found those with probable obstructive sleep ap…
New Drug Application Filed for Diazepam Nasal Spray—an Investigational Treatment for Acute Repetitive Seizures
Tuesday, September 25, 2018—A new drug application has been filed with the Food and Drug Administration (FDA) for diazepam nasal spray (Valtoco; Neurelis, San Diego, CA), which is being investigated as a…
Presence of Nighttime Seizures May Increase Risk of Death in Patients With Epilepsy
Monday, September 24, 2018—Researchers have found that having nighttime seizures, especially generalized seizures at night, increases the risk of sudden unexpected death in epilepsy (SUDEP).(Neurology:S…
Phase 3 Trial of Low-Dose Fenfluramine for Lennox-Gastaut Syndrome Is Enrolling Patients
Tuesday, September 04, 2018—In a phase 2 open-label study of the orphan drug fenfluramine (ZX008; Zogenix, Emeryville, CA) for treatment of patients with Lennox-Gastaut Syndrome (LGS) refractory to treat…
Seeking Breakthroughs: The Physician Perspective
September 2018—A roundtable discussion with Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhD
Seeking Breakthroughs: The Startup Perspective
September 2018—A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin Therapeutics
Neurologists Wanted!
Rachel Gottlieb-Smith, MD
September 2018—A recently graduated resident and new professor recommends ways to attract medical students to the specialty of neurology.
Seeking Breakthroughs: The Industry Perspective
September 2018—A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCB
